Cargando…
Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs
BACKGROUND: The U.S. Physician Payments Sunshine Act mandates the reporting of payments or items of value received by physicians from drug, medical device, and biological agent manufacturers. The impact of these payments on physician prescribing has not been examined at large scale. METHODS: We link...
Autores principales: | Perlis, Roy H., Perlis, Clifford S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868346/ https://www.ncbi.nlm.nih.gov/pubmed/27183221 http://dx.doi.org/10.1371/journal.pone.0155474 |
Ejemplares similares
-
Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data
por: Sharma, Manvi, et al.
Publicado: (2018) -
Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin
por: Hartung, Daniel M., et al.
Publicado: (2018) -
Medicare and Medicaid Physician Payment Incentives
por: Burney, Ira L., et al.
Publicado: (1979) -
Accuracy of Attestation Among Micrographic Dermatologic Surgery Diplomates
por: Perlis, Clifford S., et al.
Publicado: (2022) -
Cost Savings and Physician Responses to Global Bundled Payments for Medicare Heart Bypass Surgery
por: Cromwell, Jerry, et al.
Publicado: (1997)